{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:20:39Z","timestamp":1791354039816,"version":"4.3.1"},"reference-count":30,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100017816","name":"AIDS Institute, New York State Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017816","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Viral Hepatitis"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Hepatitis C virus (HCV) infection disproportionately impacts people who inject drugs (PWID). Understanding the prevalence and correlates of current and lifetime HCV infection is necessary to inform prevention, testing and treatment efforts among PWID to reduce HCV burden and achieve HCV elimination targets in this population From June 2021\u2013December 2023, 751 PWID were recruited from syringe service harm reduction programs (SSP) and by referral from communities around New York State (NYS). Participants completed web\u2010based surveys on risk factors and social determinants of health and were tested for HCV antibody and RNA to assess their current and lifetime HCV status (never infected, previously infected, or currently infected). Controlling for recruitment site as a fixed effect, a multivariate mixed logistic regression model was built to assess factors significantly associated with HCV status. Among PWID, 58% had a lifetime history of infection, and 29% were currently infected (50% among those with a lifetime history of infection). Daily\/almost\u2010daily injection, opioid injection, homelessness, and experience of abscess (all past\u2010year) were significantly associated with current infection, as was younger age. Past\u2010year SSP utilization was associated with a lifetime history of infection. PWID are a priority population to achieve HCV elimination in NYS. Our findings show that HCV burden is high among PWID utilizing SSPs. Expanding access to HCV care and treatment in harm reduction service settings while also providing services to address social determinants of health may be an effective strategy to progress towards reducing the burden of HCV among PWID.<\/jats:p>","DOI":"10.1111\/jvh.70208","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T04:44:54Z","timestamp":1783658694000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Integrated Studies of Infectious Disease Elimination (\n                    <scp>InSIDE<\/scp>\n                    ): Hepatitis C Antibody and\n                    <scp>RNA<\/scp>\n                    Status of Persons Who Inject Drugs in New York State, 2021\u20132023"],"prefix":"10.1111","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1659-9508","authenticated-orcid":false,"given":"Meredith A.","family":"Barranco","sequence":"first","affiliation":[{"name":"University at Albany College of Integrated Health Sciences  Albany New York USA"},{"name":"New York State Department of Health AIDS Institute, Bureau of Hepatitis Health Care and Epidemiology  Albany New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Shufelt","sequence":"additional","affiliation":[{"name":"University at Albany College of Integrated Health Sciences  Albany New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Flanigan","sequence":"additional","affiliation":[{"name":"New York State Department of Health AIDS Institute, Bureau of Hepatitis Health Care and Epidemiology  Albany New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Wilberschied","sequence":"additional","affiliation":[{"name":"New York State Department of Health AIDS Institute, Bureau of Hepatitis Health Care and Epidemiology  Albany New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5319-2689","authenticated-orcid":false,"given":"Tomoko","family":"Udo","sequence":"additional","affiliation":[{"name":"University at Albany College of Integrated Health Sciences  Albany New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000927"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2017.304132"},{"key":"e_1_2_9_4_1","unstructured":"World Health Organization \u201cGlobal Health Sector Strategy on Viral Hepatitis 2016\u20102021. Towards Ending Viral Hepatitis \u201d(2016) https:\/\/www.who.int\/publications\/i\/item\/WHO\u2010HIV\u20102016.06."},{"key":"e_1_2_9_5_1","unstructured":"New York State Department of Health \u201cNew York State Hepatitis C Elimination Plan \u201d(2021) https:\/\/www.health.ny.gov\/diseases\/communicable\/hepatitis\/hepatitis_c\/elimination.htm."},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.15585\/MMWR.MM7228A2"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/S12889\u2010023\u201016017\u20108"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.DRUGPO.2024.104387"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2014.302142"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.DRUGALCDEP.2015.03.039"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0177341"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/S12954\u2010020\u201000385\u20100"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.3389\/FPUBH.2022.835836"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/S13722\u2010022\u201000358\u20107"},{"key":"e_1_2_9_15_1","unstructured":"S.HeardandL.Maher \u201cAustralian NSP Survey National Data Report 2019\u20132023 | Kirby Institute \u201d(2024) https:\/\/www.kirby.unsw.edu.au\/sites\/default\/files\/documents\/Australian\u2010NSP\u2010Survey\u2010national\u2010data\u2010report_2019\u20102023.pdf."},{"key":"e_1_2_9_16_1","unstructured":"Legislative Analysis and Public Policy Association \u201cSyringe Services Programs: Summary of State Laws \u201d(2025) https:\/\/legislativeanalysis.org\/syringe\u2010services\u2010programs\u2010summary\u2010of\u2010state\u2010laws\/."},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.DRUGALCDEP.2021.108527"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13735"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.YPMED.2021.106541"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.DRUGPO.2023.104222"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.DRUGALCDEP.2006.12.035"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.DRUGALCDEP.2013.03.009"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.DRUGALCDEP.2021.108797"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.DRUGALCDEP.2024.112390"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.12682"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/CID\/CIZ693"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.DRUGPO.2023.103982"},{"key":"e_1_2_9_28_1","unstructured":"HepVu \u201cHepatitis C Treatment Restrictions \u201dHepVu Tools and Resources. (2024) https:\/\/hepvu.org\/wp\u2010content\/uploads\/2024\/09\/HepVu_State_Treatment_Restriction\u201020240812.xlsx."},{"key":"e_1_2_9_29_1","unstructured":"New York State Department of Health \u201cDrug User Health \u201d(2024) https:\/\/www.health.ny.gov\/diseases\/aids\/consumers\/prevention\/."},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/HEP4.1646"},{"key":"e_1_2_9_31_1","unstructured":"J.McKinney \u201cFDA Permits Marketing of First Point\u2010of\u2010Care Hepatitis C RNA Test \u201dU.S. Food & Drug Administration. June 27 (2024) https:\/\/www.fda.gov\/news\u2010events\/press\u2010announcements\/fda\u2010permits\u2010marketing\u2010first\u2010point\u2010care\u2010hepatitis\u2010c\u2010rna\u2010test."}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvh.70208","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jvh.70208","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvh.70208","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T04:43:21Z","timestamp":1785300201000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jvh.70208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1111\/jvh.70208"],"URL":"https:\/\/doi.org\/10.1111\/jvh.70208","archive":["Portico"],"relation":{},"ISSN":["1352-0504","1365-2893"],"issn-type":[{"value":"1352-0504","type":"print"},{"value":"1365-2893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"2026-04-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70208"}}